LKB1 inactivation in endometrial cancers resulted in high responsiveness to mTOR inhibitors [79], and rapamycin monotherapy (mTORC1 inhibitor) decreased polyp burden and size in LKB1+/− mice with polyposis [62]. Here, STK11 is linked to polyposis.